50 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases.
Purdue University
Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases.
Korea Research Institute of Bioscience and Biotechnology
Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters.
University of Alberta
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China.
Qufu Normal University
Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses.
Univ. Lille
Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective.
University of Siena
Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors.
Peking University
Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors.
Purdue University
Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors.
Development Center For Biotechnology
Two Binding Sites of SARS-CoV-2 Macrodomain 3 Probed by Oxaprozin and Meclomen.
University of Science and Technology of China
7-phenoxy-N-(3-azabicyclo[3.2.1]octan-8-yl-6,7-dihydro-5H-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma- secretase modulators for the treatment of alzheimer's disease
Hoffmann-La Roche
Compounds having PDE9A inhibitory activity, and pharmaceutical uses thereof
Korea Research Institute of Chemical Technology
SALT TYPES OF TRICYCLIC TETRAHYDRO ISOQUINOLINE DERIVATIVE
Jiangsu Hengrui Pharmaceuticals
Substituted pyrazolo[1,5-a]pyridine compound, composition containing the same and use thereof
Shenzhen Targetrx
3-[(1H-PYRAZOL-R-YL)OXY]PYRAZIN-2-AMINE COMPOUNDS AS HPK1 INHIBITOR AND USE THEREOF
Beigene
METHODS OF TREATING ACUTE RESPIRATORY DISTRESS SYNDROME WITH ACTIVATORS OF TIE-2
Aerpio Pharmaceuticals
Pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
Hoffmann-La Roche
BENZOTHIAZOLE AND QUINOLINE DERIVATIVES FOR USE IN TREATING KAWASAKI DISEASE
Shanghai Yao Yuan Biotechnology Co.
INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE
Cornell University
PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS
Actelion Pharmaceuticals
SUBSTITUTED BENZO[f][l ,2,4JTRIAZOL0[4,3-a][l ,4JDIAZEPINES AS GABA A GAMMA! POSITIVE ALLOSTERIC MODULATORS
Hoffmann-La Roche
N-(2-(3-CYANO-2-AZABICYCLO[3.1.0]HEXAN-2-YL)-2-OXOETHYL)QUINOLINE-4-CARBOXAMIDES
Astrazeneca
Compound having PD-L1 inhibitory activity, preparation method therefor and use thereof
Shanghai Ennovabio Pharmaceuticals
CDK6/DYRK2 DUAL-TARGET INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Jiangsu Tasly Diyi Pharmaceutical
Inhibitors of receptor interacting protein kinase I for the treatment of disease
University Of Texas
Compounds and methods for the enhanced degradation of targeted proteins
Arvinas Operations
Quaternary lactam compound and pharmaceutical use thereof
Shanghai Meiyue Biotech Development
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
University of Pittsburgh
2,4-disubstituted pyrimidines as CDK inhibitors
Shanghai Xunhe Pharmaceutical Technology
Inhibitors of pyruvate kinase and methods of treating disease
Beth Israel Deaconess Medical Center